Holen Sie sich die Stockscreener-App
8.33
1.65%
-0.14
Handel nachbörslich:
8.36
0.03
+0.36%
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Down 16.3% in October - MarketBeat
Sandoz, Amneal Get Mixed Ruling in State Drug Price-Fixing Case - Bloomberg Law
AMNEAL PHARMACEUTICALS, INC. (AMRX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Amneal Pharmaceuticals' SWOT analysis: generic drug maker's stock poised for growth - Investing.com
Amneal stock target gets a boost, overweight on strong Q3 results - Investing.com Canada
Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 12-Month High Following Analyst Upgrade - MarketBeat
Piper Sandler Issues Positive Forecast for Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price - MarketBeat
Revenues Working Against Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) Share Price - Simply Wall St
Amneal Pharmaceuticals Inc (AMRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Earnings call: Amneal Pharmaceuticals sees a 13% revenue surge in Q3 2024 - Investing.com
Amneal Pharmaceuticals (AMRX) Surpasses Q3 Earnings and Revenue Estimates - MSN
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2024 Earnings Call Transcript - MSN
Nisa Investment Advisors LLC Sells 221,848 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat
Amneal Pharma A earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Amneal Pharmaceuticals Reports Q3 2024 Financial Results - TipRanks
Amneal: Q3 Earnings Snapshot - The Washington Post
Amneal Reports Third Quarter 2024 Financial Results - BioSpace
Amneal (AMRX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts - Yahoo Finance UK
Amneal Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Amneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2024 Earnings Guidance - MarketBeat
Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for the Full Year 2024 - Marketscreener.com
Amneal Pharmaceuticals reports Q3 adjusted EPS 16c, consensus 13c - TipRanks
Amneal Pharmaceuticals Swings to 3Q Loss While Sales Climb - MarketWatch
Teva Fails To Convince Judge Inhaler Patents Require Drug - Law360
Amneal (AMRX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - MSN
Zacks.com featured highlights include Amneal Pharmaceuticals, Cronos Group, Carriage Services, Business First Bancshares and Amphenol - Yahoo Finance
Panel Discussion on ‘Next growth frontiers for India Pharma Inc' - Express Pharma
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline - MSN
Amneal Pharmaceuticals (AMRX) Scheduled to Post Earnings on Friday - MarketBeat
Amneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211% - Yahoo Finance
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Update - MarketBeat
Top Companies in the Phenazopyridine Market Set for Success - openPR
Assenagon Asset Management S.A. Purchases 642,065 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Amneal wins FDA approval for nerve agent pretreatment - Investing.com
Amneal wins FDA approval for nerve agent pretreatment By Investing.com - Investing.com Australia
Amneal Pharmaceuticals Gets FDA Approval for Pyridostigmine Bromide - MarketWatch
Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets - Business Wire
Amneal Pharmaceuticals (NASDAQ:AMRX) Sets New 12-Month HighWhat's Next? - MarketBeat
SG Americas Securities LLC Invests $531,000 in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat
AMRX Stock Soars to 52-Week High, Reaching $8.94 - Investing.com
Cardiac Sarcoidosis Drugs Global Market Report |Hikma Pharmaceuticals PLC, Mylan N.V, Amneal Pharmaceuticals LLC, Mallin – IndiaPolitics.com - IndiaPolitics.com
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Azathioprine Tablets Industry to Witness an Outstanding Growth by 2030 |Mylan, Zydus Pharmaceuticals, Amneal Pharmaceuti – IndiaPolitics.com - IndiaPolitics.com
Glycopyrrolate Injection Market Growth Report |Accord Healthcare, Advanz Pharma, American Regent, Amneal Pharmaceuticals – IndiaPolitics.com - IndiaPolitics.com
Amneal Pharma to build two new manufacturing facilities in Ahmedabad - Medical Dialogues
Amneal to Build Two Manufacturing Facilities in Ahmedabad, Gujarat - Chemical Industry Digest
Weight loss drugs to be produced in two new plants in India - Investment Monitor
Sei Investments Co. Grows Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat
0.79%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):